Growing Awareness and FDA Initiatives to Propel Zika Virus Testing Market Ahead

Pune, India, September, 2022 /press release/- Market Research Future Published a Half-Cooked Research Report on Zika Virus Testing Market Research Report.

Overview:

The Zika Virus Testing Market is expected to reach USD 179.19 Million by 2030 at 7.60% CAGR during the forecast period 2022-2030

The daunting sway zika virus had held over the populace in recent past has a far-reaching impact on governments in terms of initiatives undertaken. FDA had recently made it mandatory for zika virus testing of all the blood testing done across the U.S. in hospitals and laboratories just to keep the virus at bay. Borne by Aedes genus of mosquitoes, this disease can be easily transmitted to another person even via sexual intercourse and pregnant women, if affected, can forward that to her newborn child as well. These initiatives have resulted in the growth of zika virus testing market, and the market is all set to witness a considerable hike during the forecast period (2017-2023), asserts Market Research Future (MRFR) in an extensively analyzed report. FDA and the U.S. government have taken considerable steps to outclass this disease by having it properly tested and developing drugs that can contain the virus. The outcome is quite overwhelming. The World Health Organization (WHO) is also quite aware of the impacts of the virus and has taken steps accordingly. For instance, in 2016, it had declared a health emergency in the Americas, where the disease was spreading its wings. Subsequently, testing kits for the disease found a significant market and started growing in leaps and bounds. These precautionary decisions can act like a global market booster for the zika virus testing.

Industry Trend:

Researchers from Brigham and Women’s hospital have recently come out with their discovery where they have used nanotechnology and digital health systems to detect zika virus. In the process. They have involved smartphones as necessary equipment for the testing. The method is known as nanomotor-based bead-motion cellphone (NBC) system, which can have considerable impacts in afflicted regions.

Technology firm Inovatech, in collaboration with the São Paulo Research Foundation, developed a test at the Butantan Institute that can detect antibodies against zika virus in samples with great precision to declare infection, if any, caused by the virus previously.

Segmentation:

The global zika virus testing market can be segmented by tests and end-users.

By tests, the market can be further sub-segmented into serological/Zika virus antibody and molecular/nucleic acid amplification. The latter is the most commonly used test for zika virus detection.

Based on end-users the market includes diagnostic units, hospitals, pathology labs, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Zika Virus Testing Market Research Report

Regional Analysis

Region-specific analysis of the global market has regions Asia Pacific (APAC), Europe, Americas, and the Middle East and Africa (MEA) under its coverage.

The Americas are in-charge of the market and Latin American countries, where the outbreak of the disease hit massively, are contributing more than the regions far in the distance. Projects initiated by Health and Human Services (HHS), and Biomedical Advanced Research and Development Authority (BARDA) to deter the disease from further growth and cure the affected populace can be seen as a market influencer. Brazil’s National Development Bank (BNDES) has also infused USD 136.6 million for further researches that can help the market grow considerably.

Competitive Analysis:

The market is witnessing constant evolution owing to companies launching innovative technologies to detect the virus and cure the effects. However, collaborations are also abounding such as technology firm Inovatech’s collaboration with Sao Paolo’s Research Foundation.

Prominent companies playing a significant role in the zika virus testing market are Luminex Corporation, ARUP Laboratories, Roche Molecular Systems, Hologic, and Siemens Healthcare Diagnostics.